Gemcitabine in combination with cisplatin (GP) versus gemcitabine (G) alone in the treatment of locally advanced or metastatic pancreatic cancer: Final results of a multicenter randomized phase II study.

被引：0
|
作者：
Viret, F
Ychou, M
Lepille, D
Mineur, L
Navarro, F
Topart, D
Fonck, M
Goineau, J
Madroszyk-Flandin, A
Chouaki, N
机构：
[1] Inst J Paoli I Calmettes, F-13009 Marseille, France
[2] Ctr Val Aurelle, Montpellier, France
[3] Clin Pasteur, Evreux, France
[4] Clin St Catherine, Avignon, France
[5] Hop Caremeau, Nimes, France
[6] Inst Bergonie, Bordeaux, France
[7] Hop Louis Pasteur, Colmar, France
[8] CHU Jean Minjoz, Besancon, France
[9] Lilly, Suresnes, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4118
引用
收藏
页码：342S / 342S
页数：1
相关论文
共 50 条
  • [41] A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer
    El-Rayes, BF
    Zalupski, MM
    Shields, AF
    Ferris, AM
    Vaishampayan, U
    Heilbrun, LK
    Venkatramanamoorthy, R
    Adsay, V
    Philip, PA
    INVESTIGATIONAL NEW DRUGS, 2005, 23 (06) : 583 - 590
  • [42] Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
    Cascinu, Stefano
    Berardi, Rossana
    Bianco, Roberto
    Bilancia, Domenico
    Zaniboni, Alberto
    Ferrari, Daris
    Mosconi, Stefania
    Spallanzani, Andrea
    Cavanna, Luigi
    Leo, Silvana
    Negri, Francesca
    Beretta, Giordano D.
    Sobrero, Alberto
    Banzi, Maria
    Morabito, Alberto
    Bittoni, Alessandro
    Marciano, Roberta
    Ferrara, Domenica
    Noventa, Silvia
    Piccirillo, Maria C.
    Labianca, Roberto
    Mosconi, Cristina
    Gardini, Andrea Casadei
    Gallo, Ciro
    Perrone, Francesco
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 422 - 429
  • [43] A randomized phase II study comparing gemcitabine plus nadroparine versus gemcitabine in patients with locally advanced or metastatic pancreatic carcinoma: The GEMFRAX trial.
    Voorthuizen, T. V.
    Vervenne, W. L.
    Van Daalen, E. H.
    Phoa, S. S.
    Gouma, D. J.
    Bruno, M. J.
    Richel, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 205S - 205S
  • [44] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [45] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Song, Hong Suk
    Do, Young Rok
    Chang, Heung Moon
    Ryu, Min Hee
    Lee, Kyung Hee
    Kim, Yeul Hong
    Hong, Dae Sik
    Cho, Jae Yong
    Lee, Kyoung Eun
    Kim, Si Young
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 763 - 768
  • [46] A phase II study of isoflavone, gemcitabine, and erlotinib in locally advanced (LA) or metastatic pancreatic cancer
    Hammad, N.
    Philip, P. A.
    Shields, A. F.
    Sarkar, F. H.
    Abruzzese, J. L.
    Kaseb, A. O.
    Javle, M. M.
    Varadhachary, G. R.
    Wolff, R. A.
    El-Rayes, B. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Capecitabine plus oxaliplatin (CapOx) versus capecitabine plus gemcitabine (CapGem) versus gemcitabine plus oxaliplatin (mGemOx): final results of a multicenter randomized phase II trial in advanced pancreatic cancer
    Boeck, S.
    Hoehler, T.
    Seipelt, G.
    Mahlberg, R.
    Wein, A.
    Hochhaus, A.
    Boeck, H. -P.
    Schmid, B.
    Kettner, E.
    Stauchlo, M.
    Lordick, F.
    Ko, Y.
    Geissler, M.
    Schoppmeyer, K.
    Kojouharoff, G.
    Golf, A.
    Neugebauer, S.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 340 - 347
  • [48] Treatment of locally advanced and metastatic hepatocellular carcinoma (HCC) with gemcitabine (G) cisplatin (C) combination
    Granetto, C.
    Fea, E.
    Colantonio, I
    Di Costanzo, G.
    Garrone, O.
    Gasco, M.
    Occelli, M.
    Heouaine, A.
    Numico, G.
    Merlano, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 32 - 32
  • [49] Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma:: Final results of a GERCOR multicenter phase II study
    Louvet, C
    André, T
    Lledo, G
    Hammel, P
    Bleiberg, H
    Bouleuc, C
    Gamelin, E
    Flesch, M
    Cvitkovic, E
    de Gramont, A
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1512 - 1518
  • [50] Gemcitabine in combination with capecitabine compared with gemcitabine combined with erlotinib in locally advanced or metastatic pancreatic cancer
    Khatri, P.
    Kumari, P.
    Beniwal, S.
    Samdariya, S.
    ANNALS OF ONCOLOGY, 2016, 27 : 92 - 92
12345